Search

Author/Creator Moore, Penny L

1. Advancing HIV Vaccine Research With Low-Cost High-Performance Computing Infrastructure: An Alternative Approach for Resource-Limited Settings. Issue 13 (November 2019)

Authors:
Mabvakure, Batsirai M; Rott, Raymond; Dobrowsky, Leslie; Van Heusden, Peter; Morris, Lynn; Scheepers, Cathrine; Moore, Penny L
Journal:
Bioinformatics and biology insights
Issue:
Volume 2019:Issue 13(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial. Issue 3 (March 2023)

Authors:
Madhi, Shabir A; Kwatra, Gaurav; Richardson, Simone I; Koen, Anthonet L; Baillie, Vicky; Cutland, Clare L; Fairlie, Lee; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Ahmed, Khatija; Aley, Parvinder K; Bhikha, Sutika; Bhorat, A E; Esmail, Aliasga...
Journal:
Lancet infectious diseases
Issue:
Volume 23:Issue 3(2023)
Page Start:
295
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection. (9th February 2021)

Authors:
Dorfman, Jeffrey R; Balla, Sashkia R; Pathirana, Jayani; Groome, Michelle J; Madhi, Shabir A; Moore, Penny L
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 4(2021)
Page Start:
e981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Issue 9 (September 2021)

Authors:
Madhi, Shabir A; Koen, Anthonet L; Izu, Alane; Fairlie, Lee; Cutland, Clare L; Baillie, Vicky; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Aley, Parvinder K; Bhikha, Sutika; Hermanus, Tandile; Horne, Elizea; Jose, Aylin; Kgagudi, Prudence; Lamb...
Journal:
Lancet
Issue:
Volume 8:Issue 9(2021)
Page Start:
e568
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial. Issue 4 (April 2023)

Authors:
Mahomed, Sharana; Garrett, Nigel; Capparelli, Edmund V; Osman, Farzana; Mkhize, Nonhlanhla N; Harkoo, Ishana; Gengiah, Tanuja N; Mansoor, Leila E; Baxter, Cheryl; Archary, Derseree; Yende-Zuma, Nonhlanhla; Samsunder, Natasha; Carlton, Kevin; Narpala, Sandeep; McDermott, Adrian B; Doria-Rose, Nico...
Journal:
Lancet
Issue:
Volume 10:Issue 4(2023)
Page Start:
e230
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention. (4th February 2022)

Authors:
Mahomed, Sharana; Garrett, Nigel; Capparelli, Edmund V; Osman, Farzana; Harkoo, Ishana; Yende-Zuma, Nonhlanhla; Gengiah, Tanuja N; Archary, Derseree; Samsunder, Natasha; Baxter, Cheryl; Mkhize, Nonhlanhla N; Modise, Tandile; Carlton, Kevin; McDermott, Adrian; Moore, Penny L; Karim, Quarraisha Abd...
Journal:
Journal of infectious diseases
Issue:
Volume 226:Number 3(2022)
Page Start:
510
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗